Therini Bio
Developer of biotechnology drugs designed to offer a potential treatment to protect the nervous system from multiple sclerosis damage. The company is engaged in the development of antibodies that are ...
Valuation
$100M
Market implied
Share Price
N/A
Total Raised
$101.5M
Last Round
N/A